Understanding the Phenytoin (Epanutin) Blood Test

Phenytoin, widely known by the brand name Epanutin, is a cornerstone medication for controlling epileptic seizures. In my clinical practice, I regularly see patients who need careful monitoring of their blood phenytoin levels because the difference between an effective dose and a toxic one is surprisingly narrow. This test measures the concentration of phenytoin in your bloodstream to ensure you are getting the maximum benefit with minimal risk of side effects.

The test is typically ordered for people already taking phenytoin – it is not a diagnostic test for epilepsy itself. Instead, it falls under therapeutic drug monitoring (TDM). The goal is to keep your level within a well-established ‘therapeutic window’ where seizures are controlled without causing toxicity.

Why This Test Matters

Phenytoin has a unique pharmacokinetic profile: it follows zero-order kinetics, meaning that small increases in dose can lead to disproportionately large rises in blood concentration. I’ve seen countless patients who feel perfectly well one day and then develop dizziness, slurred speech, or unsteadiness after a modest dose adjustment. Routine monitoring helps prevent these episodes.

Several factors can alter phenytoin levels – changes in other medications, liver function, pregnancy, or even generic brand switches. That is why your doctor may request this test if you start a new medicine, experience breakthrough seizures, or develop suspicious symptoms.

Reference Ranges for Phenytoin

The therapeutic range is remarkably consistent across age groups, though very young children and elderly individuals may have slightly different targets. Below are the typical reference ranges used in most UK and US laboratories. Note: Always interpret results in context; your clinician may aim for a lower or higher level depending on seizure type and co‑morbidities.

Patient Group	Total Phenytoin (mcg/mL)	Total Phenytoin (µmol/L)
Adults (general)	10 – 20	40 – 80
Children (1 month – 15 years)	10 – 20	40 – 80
Neonates (0 – 4 weeks)	8 – 15	32 – 60
Elderly ( > 65 years)	8 – 18	32 – 72
Pregnancy (third trimester)	5 – 10 (free level often used)	20 – 40

Many laboratories now offer free phenytoin measurement, which is less affected by protein binding changes (e.g., in pregnancy, kidney disease, or when taking valproate). For free phenytoin, the therapeutic range is 1 – 2 mcg/mL (4 – 8 µmol/L).

What Does a High Phenytoin Level Mean?

A level above 20 mcg/mL (80 µmol/L) is considered supratherapeutic and may cause toxicity. My patients often describe the early signs as a spinning sensation, double vision, or feeling ‘drunk’ without alcohol. As levels climb, slurred speech, poor coordination (ataxia), and nystagmus (rapid eye movements) become apparent. Severely high levels above 40 mcg/mL can lead to stupor, coma, or even seizures. If you experience any of these, contact your doctor immediately.

Managing High Phenytoin Levels

Treatment depends on the situation. For mild elevations, simply holding one or two doses usually brings the level down safely. For significant toxicity, hospital admission for monitoring and, in rare cases, haemodialysis may be needed. Never abruptly stop phenytoin without medical guidance, as this can trigger rebound seizures.

What Does a Low Phenytoin Level Mean?

A level below 10 mcg/mL (40 µmol/L) is subtherapeutic and may not provide adequate seizure control. Many patients do not experience symptoms directly from the low level, but they might notice an increase in seizure frequency or severity. When I see a subtherapeutic result, I first check for adherence (missed doses) and then consider whether the dose needs adjustment or if an interaction with another drug is lowering the level.

Phenytoin During Pregnancy and Breastfeeding

Pregnancy significantly alters phenytoin metabolism. Total phenytoin levels often fall due to lower albumin and increased clearance, yet the free (active) portion may remain unchanged or even rise. That is why many specialists monitor free phenytoin in pregnant women. Uncontrolled seizures pose risks to both mother and fetus, so maintaining effective therapy is critical. Phenytoin does cross the placenta and has been associated with a small increased risk of congenital malformations (‘fetal hydantoin syndrome’), but the absolute risk is low. Breastfeeding is generally considered safe because levels in breast milk are low.

How Is the Test Performed?

A simple blood sample is taken from a vein, usually in your arm. The timing is important – levels are typically drawn just before your next dose (trough level) or about 4–6 hours after an oral dose (peak level). Your doctor will advise you on the best timing. No special preparation is needed, but always let the phlebotomist know if you are on any other medications or supplements.

Factors That Can Affect Your Phenytoin Level

Drug interactions: Common culprits include valproate, carbamazepine, cimetidine, fluconazole, and certain antibiotics.
Liver disease: Impaired liver function slows phenytoin clearance.
Kidney disease: Uraemia can alter protein binding.
Generic substitution: Different brands may have slightly different bioequivalence; switching can cause level changes.
Non‑adherence: Missing doses is the most common cause of subtherapeutic levels.

Phenytoin (Epanutin) Test: Levels, Range & Toxicity